2024 ESC guidelines for the management of chronic coronary syndromes: developed by the task force for the management of chronic coronary syndromes of the …

C Vrints, F Andreotti, KC Koskinas… - European heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American …

Writing Committee Members, M Gulati, PD Levy… - Journal of the American …, 2021 - jacc.org
Aim This clinical practice guideline for the evaluation and diagnosis of chest pain provides
recommendations and algorithms for clinicians to assess and diagnose chest pain in adult …

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association …

Writing Committee Members, SS Virani… - Journal of the American …, 2023 - jacc.org
Abstract Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …

[HTML][HTML] Deep learning-enabled coronary CT angiography for plaque and stenosis quantification and cardiac risk prediction: an international multicentre study

A Lin, N Manral, P McElhinney, A Killekar… - The Lancet Digital …, 2022 - thelancet.com
Background Atherosclerotic plaque quantification from coronary CT angiography (CCTA)
enables accurate assessment of coronary artery disease burden and prognosis. We sought …

Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial

MJ Budoff, DL Bhatt, A Kinninger… - European Heart …, 2020 - academic.oup.com
Aims Despite the effects of statins in reducing cardiovascular events and slowing
progression of coronary atherosclerosis, significant cardiovascular (CV) risk remains …

[HTML][HTML] Ultra-high-resolution coronary CT angiography with photon-counting detector CT: feasibility and image characterization

V Mergen, T Sartoretti, M Baer-Beck… - Investigative …, 2022 - journals.lww.com
Objectives The aim of this study was to evaluate the feasibility and quality of ultra-high-
resolution coronary computed tomography angiography (CCTA) with dual-source photon …

Coronary Computed Tomography Angiography From Clinical Uses to Emerging Technologies: JACC State-of-the-Art Review

KM Abdelrahman, MY Chen, AK Dey, R Virmani… - Journal of the American …, 2020 - jacc.org
Abstract Evaluation of coronary artery disease (CAD) using coronary computed tomography
angiography (CCTA) has seen a paradigm shift in the last decade. Evidence increasingly …

Role of omega-3 fatty acids in cardiovascular disease: the debate continues

SCR Sherratt, P Libby, MJ Budoff, DL Bhatt… - Current atherosclerosis …, 2023 - Springer
Abstract Purpose of Review The omega-3 fatty acids (n3-FAs), eicosapentaenoic acid (EPA)
and docosahexaenoic acid (DHA), have recently undergone testing for their ability to reduce …

Association of lipoprotein (a) with atherosclerotic plaque progression

Y Kaiser, M Daghem, E Tzolos, MN Meah… - Journal of the American …, 2022 - jacc.org
Abstract Background Lipoprotein (a)[Lp (a)] is associated with increased risk of myocardial
infarction, although the mechanism for this observation remains uncertain. Objectives This …

First in-human quantitative plaque characterization with ultra-high resolution coronary photon-counting CT angiography

V Mergen, M Eberhard, R Manka, A Euler… - Frontiers in …, 2022 - frontiersin.org
Purpose To assess the effect of ultra-high-resolution coronary CT angiography (CCTA) with
photon-counting detector (PCD) CT on quantitative coronary plaque characterization …